<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-150864</identifier>
<setSpec>0211-139X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Dementia and Tobacco</dc:title>
<dc:description xml:lang="en">The relation between consumption of tobacco and the associated risk for Alzheimer disease isn&#146;t established yet. The nicotine could increase the colinergic transmission operatin over the possitive regulation of the cerebrals nicotine receptors (nAChRS). Two types of evidence seems to support this action: 1. several estudies have concluded that the administration of nicotine to people with AD give better punctuation in neuropsycological cognitive tests; 2. epidemiological studies that use the case-control strategic, apparently fives the fact that the consume of tobacco is associated to a decrease of the relative risk for having Alzheimer Disease. However, these one are based in prevalent patients, for what devistions of the results can exist due to a high mortality of elderly smokers with dementia. When incident cases were analyzed, a relative increased risk has been observed. In this work the fisiology of nicotine receptors in Alzheimer disease is anlaysed (AU)</dc:description>
<dc:creator>Fariñas, F</dc:creator>
<dc:creator>Gil, P</dc:creator>
<dc:creator>Vázquez, R</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No se ha podido establecer todavía una relación clara entre el tabaquismo y el riesgo asociado para padecer la enfermedad de Alzheimer (EA). La nicotina podría aumentar la transmisión colinérgica actuando sobre la regulación positiva de los receptores nicotínicos cerebrales (nAChRs). Dos tipos de evidencia parecen apoyar esta acción: 1) varios estudios han concluido que la administración de nicotina a individuos con EA mejora sus puntuaciones en pruebas neuropsicológicas que evalúan la función cognitiva, y 2) estudios epidemiológicos que utilizan la estrategia caso-control, pusieron de manifiesto aparentemente que el consumo de tabaco se asocia a una disminución del riesgo relativo para padecer la EA. No obstante, estos últimos están basados en pacientes prevalentes, por lo que pueden existir desviaciones de los resultados debidas a una mayor mortalidad de los individuos dementes fumadores. Cuando se analizaron casos incidentes, se ha observado un riesgo relativo aumentado. En el trabajo se analiza la fisiología de los receptores nicotínicos en la enfermedad de Alzheimer (AU)</dc:description>
<dc:source>Rev. esp. geriatr. gerontol. (Ed. impr.);36(supl.1): 19-24, mar. 2001.</dc:source>
<dc:identifier>ibc-150864</dc:identifier>
<dc:title xml:lang="es">Demencia y tabaco</dc:title>
<dc:subject>^d545^s22053</dc:subject>
<dc:subject>^d545^s22056</dc:subject>
<dc:subject>^d545^s22012</dc:subject>
<dc:subject>^d32466^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d32466^s22011</dc:subject>
<dc:subject>^d32466^s22045</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d35251</dc:subject>
<dc:subject>^d32466^s22028</dc:subject>
<dc:subject>^d3718^s22044</dc:subject>
<dc:subject>^d545^s22016</dc:subject>
<dc:subject>^d10669^s22045</dc:subject>
<dc:subject>^d3718^s22011</dc:subject>
<dc:subject>^d9723^s22020</dc:subject>
<dc:subject>^d3718^s22056</dc:subject>
<dc:subject>^d3718^s22067</dc:subject>
<dc:subject>^d9723^s22000</dc:subject>
<dc:subject>^d10669^s22039</dc:subject>
<dc:type>article</dc:type>
<dc:date>200103</dc:date>
</metadata>
</record>
</ibecs-document>
